Studies | EBMT

Top

Study type

Disease

Group

Type of transplant / Cell therapy

Text

Language

Survey on ICU organization and ICU admission after haematopoietic cell transplantation with special emphasis on infectious causes

Closed Survey/Study

Infectious Diseases Working Party (IDWP)

Complications Working Party (CWP)

Type de traitement

Investigateur principal

Joanna Drozd-Sokolowska

Infections following CAR-T therapy. A retrospective collaborative study between the Infectious Diseases Working Party (IDWP), the Cellular Therapy and Immunobiology Working Party (CTIWP), the Transplant Complications Working Party (TCWP) of the EBMT, the European Hematology Association (EHA), and the Medical College of Wisconsin.

Lymphome non hodgkinien (LNH)

Leucémie Aiguë Lymphoblastique (LAL)

GoCART Coalition

Infectious Diseases Working Party (IDWP)

Cellular Therapy & Immunobiology Working Party (CTIWP)

Complications Working Party (CWP)

Type de traitement

Investigateur principal

Autoimmune and autoinflammatory complications after CAR-T cell therapy - a joint study on behalf of the EBMT - ADWP, CTIWP and TCWP

Études rétrospectives

Leucémie Aiguë Lymphoblastique (LAL)

Myélome multiple (MM) ou autre dyscrasies plasmocytaires (PCD)

Lymphome non hodgkinien (LNH)

GoCART Coalition

Autoimmune Diseases Working Party (ADWP)

Cellular Therapy & Immunobiology Working Party (CTIWP)

Complications Working Party (CWP)

Type de traitement

Investigateur principal

Multicentric evaluation of CAR-T cell induced pseudoprogression prevalence (PrevCARTiPP)

Études rétrospectives

Toutes les maladies

Complications Working Party (CWP)

Type de traitement

Investigateur principal

Friedrich Stoelzel

Thrombotic microangiopathy (TMA) after CAR-T cell therapy

Études rétrospectives

Toutes les maladies

Complications Working Party (CWP)

Type de traitement

Investigateur principal

Guillaume Dachy

CAR-T cell outcomes in patients with comorbidities

Études rétrospectives

Toutes les maladies

Complications Working Party (CWP)

Type de traitement

Investigateur principal

Impact of body mass index on outcome of CART cell therapy

Études rétrospectives

Toutes les maladies

Complications Working Party (CWP)

Type de traitement

Investigateur principal

Christian Schultze-Florey

Survey on the use of SGLT2 inhibitors in cell therapy including autologous and allogeneic hematopoietic stem cell transplantation and CART cell therapy

Toutes les maladies

Complications Working Party (CWP)

Type de traitement

Investigateur principal

Christian Schultze-Florey

Steroid-free first line treatment of moderate and severe chronic GVHD - restrospective study

Retrospective Studies

Complications Working Party (CWP)

Type de traitement

Investigateur principal

Effects of donor clonal hematopoiesis in unrelated HSCT

Retrospective Studies

Complications Working Party (CWP)

Type de traitement

Investigateur principal

F. Damm & J. Schetelig

Treatment Related and population mortality for Older Patients (TROP)

Retrospective Studies

Complications Working Party (CWP)

Type de traitement

Investigateur principal

Johannes Schetelig; Liesbeth de Wreede‬

Outcomes and risk factors for survival of lung transplantation after allogeneic HSCT

Retrospective Studies

Complications Working Party (CWP)

Type de traitement

Investigateur principal

Juan Montoro Gomez; Saskia Bos